Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2024

04-05-2024 | Ovarian Cancer | Gynecologic Oncology

Correspondence on “Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes” by Valentina Ghirardi et al.

Authors: Mukurdipi Ray, MS, FRCS, PhD, FACS, V. Carolin Solomi, DGO, MS(OG), DNB, MRCOG

Published in: Annals of Surgical Oncology | Issue 7/2024

Login to get access

Excerpt

Congratulations to your entire team on the wonderful article that emphasizes the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in a delayed interval cytoreductive surgery setting in stage IV patients post six cycles of neoadjuvant chemotherapy (NACT). …
Literature
1.
go back to reference Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:101–4.PubMed Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:101–4.PubMed
2.
go back to reference Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.CrossRefPubMed Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.CrossRefPubMed
3.
go back to reference Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559–64.CrossRefPubMed Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559–64.CrossRefPubMed
Metadata
Title
Correspondence on “Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes” by Valentina Ghirardi et al.
Authors
Mukurdipi Ray, MS, FRCS, PhD, FACS
V. Carolin Solomi, DGO, MS(OG), DNB, MRCOG
Publication date
04-05-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 7/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-15399-2

Other articles of this Issue 7/2024

Annals of Surgical Oncology 7/2024 Go to the issue
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare